These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6320314)

  • 1. Evidence that proglumide and benzotript antagonize secretagogue stimulation of isolated gastric parietal cells.
    Magous R; Bali JP
    Regul Pept; 1983 Nov; 7(3):233-41. PubMed ID: 6320314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists.
    Hahne WF; Jensen RT; Lemp GF; Gardner JD
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6304-8. PubMed ID: 6171817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide.
    Loewe CJ; Grider JR; Gardiner J; Vlahcevic ZR
    Gastroenterology; 1985 Oct; 89(4):746-51. PubMed ID: 2863192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines.
    Hoosein NM; Kiener PA; Curry RC; Rovati LC; McGilbra DK; Brattain MG
    Cancer Res; 1988 Dec; 48(24 Pt 1):7179-83. PubMed ID: 3191491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity of cholecystokinin receptor antagonists for the gastrin-binding protein.
    Rorison KA; Yang Z; Baldwin GS
    Eur J Pharmacol; 2000 Jan; 388(1):9-15. PubMed ID: 10657541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrin receptors on isolated canine parietal cells.
    Soll AH; Amirian DA; Thomas LP; Reedy TJ; Elashoff JD
    J Clin Invest; 1984 May; 73(5):1434-47. PubMed ID: 6325503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proglumide inhibition of trophic action of pentagastrin.
    Johnson LR; Guthrie PD
    Am J Physiol; 1984 Jan; 246(1 Pt 1):G62-6. PubMed ID: 6320664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a gastrin-type receptor on rabbit gastric parietal cells using L365,260 and L364,718.
    Roche S; Bali JP; Galleyrand JC; Magous R
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G182-8. PubMed ID: 1996638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of pancreatic growth induced by pancreatico-biliary diversion in the rat. Inhibition by proglumide, benzotript, and ranitidine.
    Miazza BM; Turberg Y; Guillaume P; Hahne W; Chayvialle JA; Loizeau E
    Scand J Gastroenterol Suppl; 1985; 112():75-83. PubMed ID: 2409583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity binding sites for gastrin on isolated rabbit gastric mucosal cells.
    Magous R; Bali JP
    Eur J Pharmacol; 1982 Aug; 82(1-2):47-54. PubMed ID: 6290232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrin and gastrin receptor antagonists bind to both N- and C-terminal halves of the 78 kDa gastrin-binding protein.
    Murphy VJ; Mantamadiotis T; Baldwin GS
    Int J Biochem Cell Biol; 1996 Nov; 28(11):1233-40. PubMed ID: 9022282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of pentagastrin-stimulated up-regulation of gastrin receptors and growth of mouse colon tumor in vivo by proglumide, a gastrin receptor antagonist.
    Singh P; Le S; Beauchamp RD; Townsend CM; Thompson JC
    Cancer Res; 1987 Oct; 47(19):5000-4. PubMed ID: 3621187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans.
    Schmidt WE; Schenk S; Nustede R; Holst JJ; Fölsch UR; Creutzfeldt W
    Gastroenterology; 1994 Dec; 107(6):1610-20. PubMed ID: 7958670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the preferential binding of actin to the N-terminal hydratase domain of the 78-kDa gastrin-binding protein by non-steroidal anti-inflammatory drugs and gastrin receptor antagonists.
    Baldwin GS
    Biochem Pharmacol; 2001 May; 61(9):1129-36. PubMed ID: 11301046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of proglumide on pancreatic acinar cell function.
    Williams JA; Bailey A; Steigerwalt RW
    Digestion; 1983; 27(4):227-33. PubMed ID: 6197332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proglumide (gastrin and cholecystokinin receptor antagonist) inhibits insulin secretion in vitro.
    Verspohl EJ; Wunderle G; Ammon HP; Williams JA; Goldfine ID
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):284-7. PubMed ID: 3012373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are C-terminal octapeptide of cholecystokinin and [Leu11]gastrin-(5-17) different in stimulating acid secretion in isolated rabbit gastric glands?
    Oiry C; Galleyrand JC; Lima-Leite AC; Fulcrand P; Martinez J
    Eur J Pharmacol; 1995 Dec; 294(2-3):511-9. PubMed ID: 8750713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of gastrin-stimulated growth of gastrointestinal tumour cells by octreotide and the gastrin/cholecystokinin receptor antagonists, proglumide and lorglumide.
    Watson SA; Morris DL; Durrant LG; Robertson JF; Hardcastle JD
    Eur J Cancer; 1992; 28A(8-9):1462-7. PubMed ID: 1355350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
    Crawley JN; Stivers JA; Hommer DW; Skirboll LR; Paul SM
    J Pharmacol Exp Ther; 1986 Feb; 236(2):320-30. PubMed ID: 3003339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin.
    Niederau C; Ferrell LD; Grendell JH
    Gastroenterology; 1985 May; 88(5 Pt 1):1192-204. PubMed ID: 2984080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.